Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
New weight loss drugs could be developed much faster if Roche gets its way
Roche told investors on Monday that it plans to make significant cuts to both the cost and time it takes for it to develop new drugs, including its slate of experimental weight loss and diabetes medications.
Popular Weight Loss Drugs Now for Patients With Cancer?
Some oncologists are turning to GLP-1 agents to help patients shed excess pounds, with the goal of improving cancer outcomes. But data on the practice remain limited.
Roche plans to launch 13 drugs and slash development costs
Roche is planning to launch 13 medicines by the end of the decade and cut research costs for new drugs by a fifth, according to a strategy update on Monday. Thomas Schinecker, chief executive of the Swiss pharmaceutical company,
FierceBiotech
9h
Rivus reveals data to back up muscle-sparing claims of phase 2 obesity drug
Rivus already announced in August that the trial hit its key endpoint, but today fleshed out that win with some figures.
13h
Roche Confirms Narrowed Pharma Focus, Fast Tracks Obesity-Drug Candidate -- Update
Roche said it plans to focus on five key therapeutic areas as part of its new pharma strategy through 2030. The company will prioritize work in the areas of neurology, oncology and hematology, ...
STAT
10d
Novo’s new obesity drug shows modest results, raises concerns of psychiatric side effects
A next-generation obesity drug candidate from Novo Nordisk produced modest weight loss, along with a higher rate of some ...
Morningstar
7d
Obesity Drugs: Can New Firms Take Market Share From Eli Lilly and Novo Nordisk?
While initially approved for diabetes, GLP-1
drugs
are gaining
new
indications, including the large opportunity in ...
5d
Obesity drug developer BioAge Labs aims up to $640 mln valuation in upsized US IPO
BioAge Labs is eyeing a valuation of up to $639.7 million in its upsized initial public offering in the United States, the ...
11d
Research That Led to Obesity Drugs Wins Major Medical Prize
Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to ...
5d
Obesity Experts’ Go-to Oral Medication — That Your Primary Doctor May Not Know About
Sometimes diet and exercise are not enough to help the 100 million Americans with obesity lose weight and prevent health ...
12h
Roche targets more than $3 billion in annual obesity sales
Roche said on Monday that three early-stage obesity and diabetes drug candidates from its acquisition of Carmot Therapeutics ...
4d
on MSN
New weight loss drugs spark eating disorder concerns in teens
BOSTON - There is concern over the newest weight loss drugs sparking eating disorders in teens. Newer GLP-1 weight loss drugs ...
6d
on MSN
Severe obesity is on the rise in the US
Obesity is high and holding steady in the U.S. About 4 in 10 Americans have obesity overall and about 1 in 10 have severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Roche
Eli Lilly and Company
Feedback